Immunofluorescence Analyzer Market To Witness An Outstanding Growth By 2026

Review, Outlook, Future Analysis And
Synthesis By 2025
Immunoassays are biochemical tests that are used to quantify a specific substance or detect an
analyte in body fluid sample or in the blood using an antibody or antigen. Immunoassays are
highly specific due to the use of purified antigens and antibodies as reagents and it is sensitive.
The common uses of immunoassay include hormones, measurement of drugs, tumor markers,
markers of cardiac injury, and specific proteins. Immunofluorescence assays are different type of
immunoassays. The advantages of a fluorescent detection system include higher sensitivity
recognition of an analyte, simpler assay designs, and simplified reagents. Over the past few
decades various advancements such as portability, compactness and real time monitoring of
analyzer have supported the application of fluorescent-based immunoassay system in point-ofcare. A modern immunofluorescence assay-based analyzer uses a florescent compound that
absorbs light energy at a specific wavelength and emits energy at a different wavelength. The
difference between these light energy is called strokes shift. Immunofluorescence assay
analyzers are extensively used in the field of clinical diagnostics, research and development, and
quality control. Lack of skilled workforce and increasing test volume have led to the growth of
immunofluorescence analyzer market size.
Download PDF Brochure of This Research at
Immunofluorescence Analyzer Market Dynamics
Increasing number of innovative products that are developed by clinical diagnostic
manufacturers from the results of clinical and preclinical trials research is boosting the
immunofluorescence analyzer market growth. For instance, in 2016, AESKU group received
clearance from the Food and Drug Administration (FDA) for its new HELIOS automated
immunofluorescence system with AESKUSLIDES ANA HEp-2-Gamma assay. HELIOS is based
upon automated system for the immunofluorescence processing with image recapturing with an
integrated software and fluorescence microscope. In a single run, HELIOS can process and
analyze patient samples. Over 300 HELIOS systems are used worldwide in clinical research in
over 40 countries. Moreover, significance of care is now shifting towards early detection and
prevention of diseases. Therefore, private companies are investing huge amount of capital for
the development of rapid diagnostic testing solutions and low cost imaging technologies for
point-of-care testing. For instance, in 2017, the Food and Drug Administration provided
clearance to Quidel’s point-of-care Sofia® 2 immunoassay analyzer for use with Sofia influenza
A+B assay. The next generation version, Sofia 2, is based on Quidel’s bestselling Sofia
instrumented system. Sofia 2 is integrated with wireless connectivity and uses the florescent
chemistry design with optics system to provide automated, accurate results in 3 minutes.
Report includes chapters which deeply display the following deliverable about industry :
• Immunofluorescence Analyzer Market Research Objective and Assumption
• Immunofluorescence Analyzer Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Immunofluorescence Analyzer Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Immunofluorescence Analyzer Market, By Regions
• Immunofluorescence Analyzer Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Immunofluorescence Analyzer Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Immunofluorescence Analyzer Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Immunofluorescence Analyzer Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Immunofluorescence Analyzer Market – Regional Insights
On the basis of region, the global immunofluorescence analyzer market is segmented into North
America, Asia Pacific, Latin America, Europe, Middle East, and Africa. North America
immunofluorescence analyzer market accounts for the largest share in the global market, owing
to rising adoption of innovative technologies in the region. For instance, in 2017, Siemens
Healthineers launched the Atellica Solution, an immunoassay and clinical chemistry solution that
is highly flexible, which included patented magnetic bi-directional sample transport technology
that is 10 times quicker than conventional system. The solution can be used as scalable standalone system that offers 300 customizable configurations including U-shaped and L-shaped, and
is scalable up to 10 components.
Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast
period, owing to the large number of population vulnerable to various chronic diseases and
increasing adoption of new technologies. For instance, in 2014, Sysmex Corporation launched a
compact immunochemistry testing automated immunoassay system HISCL-800, which has high
degree of sensitivity, minute samples, fast measurement, and high operability as well as
Immunofluorescence Analyzer Market – Competitive Landscape
Key players operating in the global immunofluorescence analyzer market include Abbott
Laboratories, bioMerieux, EMD Millipore, Siemens Healthcare, Thermo Fisher Scientific, and
DiaSorin S.p.A. Major players are focused towards adopting strategies such as launch of new
innovative products to boost their product portfolio and hold their position in the market. For
instance, in 2017, Abbott received FDA approval for its Alinity ci-series instruments. The
portfolio includes immunoassay diagnostics, clinical chemistry, blood and plasma screening,
point-of-care, hematology, and AlinIQ holistic suite, which provides professional services with
informatics and process analysis.
Browse Report For More Information at
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Increasing number of innovative products that are developed by clinical diagnostic manufacturers from the results of clinical and preclinical trials research is boosting the immunofluorescence analyzer market growth.